TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 110 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $216 | -99.9% | 7,431 | +157.6% | 0.00% | 0.0% |
| Q1 2021 | $213,000 | -34.3% | 2,885 | -12.6% | 0.00% | -50.0% |
| Q3 2018 | $324,000 | -33.2% | 3,300 | -28.7% | 0.01% | -33.3% |
| Q4 2017 | $485,000 | -22.3% | 4,629 | -16.5% | 0.01% | -25.0% |
| Q3 2017 | $624,000 | -58.5% | 5,541 | -58.7% | 0.02% | -65.2% |
| Q2 2017 | $1,503,000 | -12.9% | 13,415 | -9.3% | 0.05% | -13.2% |
| Q1 2017 | $1,725,000 | +15.7% | 14,789 | +4.4% | 0.05% | +39.5% |
| Q4 2016 | $1,491,000 | +76.7% | 14,160 | +85.4% | 0.04% | +90.0% |
| Q3 2016 | $844,000 | +117.5% | 7,636 | +186.7% | 0.02% | +150.0% |
| Q2 2016 | $388,000 | – | 2,663 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL MANAGEMENT LP | 582,409 | $90,011,000 | 60.33% |
| GUARDIAN POINT CAPITAL, LP | 70,000 | $10,819,000 | 10.19% |
| Think Investments LP | 186,373 | $28,804,000 | 8.16% |
| Greywolf Capital Management LP | 277,936 | $42,955,000 | 7.45% |
| Valentine Capital Asset Management, Inc. | 28,431 | $4,394,000 | 4.91% |
| FORT, L.P. | 63,675 | $9,841,000 | 4.69% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 527,266 | $81,489,000 | 3.63% |
| RPG Investment Advisory, LLC | 60,910 | $9,413,000 | 3.52% |
| Kerrisdale Advisers, LLC | 81,996 | $12,672,000 | 3.24% |
| Strategic Global Advisors, LLC | 48,154 | $7,442,000 | 3.17% |